Status:
COMPLETED
Peri-neural Dexmedetomidine Versus Dexamethasone for Supraaclavicular Block Adjuvant to Bupivacaine Supraclavicular Brachial Plexus Block
Lead Sponsor:
Cairo University
Conditions:
Brachial Plexus Block
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
to assessthe impact of addition of Dexmedetomidine or Dexamethasone to Bupivacaine, on Duration of analgesia (time in hours to the first report of postoperative pain )at the surgical site
Detailed Description
This randomized, controlled double blinded study included 42 adult patients undergoing arteriovenous fistula surgery. Ultrasound-guided supraclavicular brachial plexus block was initiated after placem...
Eligibility Criteria
Inclusion
- All the patients included in the study aged 18 to 60 years old were on chronic hemodialysis and they had a hemodialysis session one day before the block performance
Exclusion
- Neurological, neuromuscular, psychiatric disorders, hepatic, respiratory, or cardiac diseases; coagulation disorders; infection at the block injection site; patients with a body mass index more than 35; or patients who refused the procedure
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 12 2020
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04694105
Start Date
June 1 2018
End Date
January 12 2020
Last Update
January 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Alini Univeristy Hospital
Cairo, Giza Governorate, Egypt, 11451